260 related articles for article (PubMed ID: 18085732)
1. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.
Kotani T; Makino S; Takeuchi T; Kagitani M; Shoda T; Hata A; Tabushi Y; Hanafusa T
J Rheumatol; 2008 Feb; 35(2):254-9. PubMed ID: 18085732
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
[TBL] [Abstract][Full Text] [Related]
3. Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia.
Kotani T; Takeuchi T; Makino S; Hata K; Yoshida S; Nagai K; Wakura D; Shoda T; Hanafusa T
Clin Rheumatol; 2011 Aug; 30(8):1021-8. PubMed ID: 21340495
[TBL] [Abstract][Full Text] [Related]
4. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
Harigai M; Hara M; Kamatani N; Kashiwazaki S
Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis.
Nagai K; Takeuchi T; Kotani T; Hata K; Yoshida S; Isoda K; Fujiki Y; Shiba H; Makino S; Hanafusa T
Mod Rheumatol; 2011 Feb; 21(1):32-6. PubMed ID: 20680374
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected].
Isoda K; Takeuchi T; Kotani T; Hata K; Shoda T; Ishida T; Yoshida S; Kimura Y; Makino S; Hanafusa T
PLoS One; 2014; 9(2):e89610. PubMed ID: 24586910
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic efficacy of cyclosporin A in four cases of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia].
Ozawa Y; Kurosaka D; Yokoyama T; Tajima N
Ryumachi; 2000 Oct; 40(5):798-809. PubMed ID: 11215158
[TBL] [Abstract][Full Text] [Related]
9. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
Carstens J
Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
[TBL] [Abstract][Full Text] [Related]
10. [A case of dermatomyositis complicated with pneumomediastinum that was successfully treated with cyclosporin A].
Nonomura Y; Koike R; Nishio J; Tsubata R; Kohsaka H; Kubota T; Miyasaka N
Ryumachi; 2001 Jun; 41(3):653-8. PubMed ID: 11505515
[TBL] [Abstract][Full Text] [Related]
11. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
12. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
[TBL] [Abstract][Full Text] [Related]
13. [Effective treatment of interstitial pneumonia with tacrolimus in a patient with dermatomyositis who was intolerant to cyclosporin-A].
Nuri K; Kotani T; Takeuchi T; Shoda T; Makino S; Hanafusa T
Nihon Kokyuki Gakkai Zasshi; 2010 Jun; 48(6):444-8. PubMed ID: 20608089
[TBL] [Abstract][Full Text] [Related]
14. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
[TBL] [Abstract][Full Text] [Related]
15. [Cyclosporin treatment of interstitial pneumonia and monitoring of serum concentration].
Enomoto N; Suda T; Hashimoto D; Naito T; Fujisawa T; Miwa S; Nakano H; Suzuki K; Yokomura K; Ide K; Chida K
Nihon Kokyuki Gakkai Zasshi; 2004 Nov; 42(11):934-40. PubMed ID: 15651272
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis].
Toyoshima M; Sato A; Chida K; Hayakawa H; Todate A; Imokawa S; Iwata M; Ohashi H; Shirai M; Yagi H
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):281-7. PubMed ID: 9168643
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oral high-trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis.
Suzuka T; Kotani T; Takeuchi T; Fujiki Y; Hata K; Yoshida S; Shoda T; Makino S; Arawaka S
Int J Rheum Dis; 2019 Feb; 22(2):303-313. PubMed ID: 30398034
[TBL] [Abstract][Full Text] [Related]
20. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
Takada K; Nagasaka K; Miyasaka N
Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
